2005Unpublished venueRequires access

The First Few Years on a Dopamine Agonist Drug (Pramipexole, Ropinirole, or Pergolide)

J. Eric Ahlskog

Open publisher page 0 citations

Abstract

Abstract In chapter 15 you read about how things typically go during the first few years of carbidopa/levodopa treatment. What if you started a dopamine agonist rather than carbidopa/levodopa after you were first diagnosed? Will the problems be the same? Will it go as smoothly? Will the dose need to be changed? Will carbidopa/levodopa be necessary and if so, when? In this chapter we will focus on these and other questions that arise when your only drug for PD is pramipexole, ropinirole, or pergolide. Parkinsonism tends to slowly worsen over months to years. This is never rapid but insidious. The dopamine agonist drugs are not as effective as carbidopa/ levodopa and they may become inadequate after one to a few years. Sometimes a dosage change is sufficient to overcome the problem, whereas in other cases, the addition of carbidopa/levodopa may be necessary.

About this research paper

What this paper is about

Abstract In chapter 15 you read about how things typically go during the first few years of carbidopa/levodopa treatment. What if you started a dopamine agonist rather than carbidopa/levodopa after you were first diagnosed? Will the problems be the same? Will it go as smoothly? Will the dose need to be changed? Will carbidopa/levodopa be necessary and if so, when? In this chapter we will focus on these and other questions that arise when your only drug for PD is pramipexole, ropinirole, or pergolide. Parkinsonism tends to slowly worsen over months to years. This is never rapid but insidious. The dopamine agonist drugs are not as effective as carbidopa/ levodopa and they may become inadequate after one to a few years. Sometimes a dosage change is sufficient to overcome the problem, whereas in other cases, the addition of carbidopa/levodopa may be necessary.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract In chapter 15 you read about how things typically go during the first few years of carbidopa/levodopa treatment. What if you started a dopamine agonist rather than carbidopa/levodopa after you were first diagnosed? Will the problems be the same? Will it go as smoothly? Will the dose need to be changed? Will carbidopa/levodopa be necessary and if so, when? In this chapter we will focus on these and other questions that arise when your only drug for PD is pramipexole, ropinirole, or pergolide. Parkinsonism tends to slowly worsen over months to years. This is never rapid but insidious. The dopamine agonist drugs are not as effective as carbidopa/ levodopa and they may become inadequate after one to a few years. Sometimes a dosage change is sufficient to overcome the problem, whereas in other cases, the addition of carbidopa/levodopa may be necessary.

Key concepts: Pergolide, Pramipexole, Ropinirole, Carbidopa, Levodopa, Dopamine agonist, Agonist, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
The First Few Years on a Dopamine Agonist Drug (Pramipexole, Ropinirole, or Pergolide) — Research Paper | ScholarLens